All Stories

  1. Late Breaking Abstract - Real-world evidence of dual bronchodilator therapy using Clinical COPD Questionnaire in 4700 COPD patients
  2. Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial
  3. Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients
  4. A double-blind, randomized, sham-controlled study of Targeted Lung Denervation in patients with moderate to severe COPD : AIRFLOW-2 One Year Outcomes
  5. Real world safety of bronchoscopic thermal vapor ablation in a multinational registry
  6. Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study
  7. Long-term safety of bilateral targeted lung denervation in patients with COPD
  8. Inhaled therapies in patients with moderate COPD in clinical practice: current thinking
  9. Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study
  10. Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD
  11. Testen Sie Ihr Fachwissen
  12. POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe
  13. Testen Sie Ihr Fachwissen
  14. Targeted lung denervation for moderate to severe COPD: a pilot study
  15. Design of the randomized, controlled sequential staged treatment of emphysema with upper lobe predominance (STEP-UP) study
  16. Testen Sie Ihr Fachwissen
  17. Lungenemphysemtherapie mit Non-Blocking Devices
  18. Soluble receptor of advanced glycation end-products and endothelial dysfunction in COPD
  19. The Role of the Nose in Obstructive Sleep Apnea: A Short Review
  20. Testen Sie Ihr Fachwissen
  21. Ambulatory management of primary spontaneous pneumothorax: the good is (not always) the enemy of the better (evidence)
  22. Pneumothorax following Endobronchial Valve Therapy and Its Impact on Clinical Outcomes in Severe Emphysema
  23. Insulin resistance may contribute to vascular dysfunction in patients with chronic obstructive pulmonary disease
  24. Testen Sie Ihr Fachwissen
  25. Endobronchial Valve-Induced Pneumatocele: A Case Report
  26. Cardiac Performance by Noninvasive Bilevel Positive Airway Pressure (BiPAP) in Acute-on-Chronic Heart Failure: Pressure Dependence or Nervous Activity
  27. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy
  28. A Case of Tracheobronchial Amyloidosis Treated with Endoscopic Debulking and External Beam Radiation Therapy
  29. Endoskopisches Management der endobronchialen Blutung
  30. Endoscopic One-Way Valve Implantation in Patients With Prolonged Air Leak and the Use of Digital Air Leak Monitoring
  31. The Localized Inflammatory Response to Bronchoscopic Thermal Vapor Ablation
  32. Gender-related Differences in the Obstructive Sleep Apnea Syndrome
  33. 1 year follow up of vapor lund volume reduction
  34. Endobronchial Valve Therapy Improves BODE Index In Patients With Advanced Emphysema
  35. Consistent Lobar Volume Reduction Throughout 12 Months Following Bronchoscopic Thermal Vapor Ablation In Patients With Upper Lobe Predominant Emphysema
  36. The Localized Inflammatory Response To Bronchoscopic Thermal Vapor Ablation (InterVapor) In Patients With Emphysema
  37. Long Term Follow-Up Of Patients Treated With Endobronchial One-Way Valves For Persistent Bronchopleural Fistulas
  38. The Influence Of GOLD Stage On The Magnitude Of Benefit Following Endoscopic Thermal Vapor Ablation (InterVaporTM) In Patients With Heterogeneous Emphysema
  39. VAPOR Trial: 12 Month Efficacy And Safety Following Endoscopic Thermal Vapor Ablation (InterVapor") For Patients With Heterogeneous Emphysema
  40. Effect of fissure integrity on lung volume reduction using a polymer sealant* in advanced emphysema
  41. Bronchoskopische Thermoablation bei Patienten mit schwerem heterogenem Lungenemphysem: 12-Monats-Daten
  42. Hypoxemia and cardiovascular disease in COPD. Not related to sleep disordered breathing after all
  43. Das Leck in der Lunge: Bronchoskopische Ventilimplantation zur Behandlung einer persistierenden bronchopleuralen Fistel
  44. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort
  45. Efficacy of Bronchoscopic Thermal Vapor Ablation and Lobar Fissure Completeness in Patients with Heterogeneous Emphysema
  46. Physiological Modeling of Responses to Upper Versus Lower Lobe Lung Volume Reduction in Homogeneous Emphysema
  47. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema
  48. Pros and Cons of Humidification for CPAP Therapy in the Treatment of Sleep Apnea
  49. Endobronchial Valves For Emphysema Palliation Trial - The Euro Vent Trial
  50. The Efficacy Of Bronchoscopic Thermal Vapor Ablation (BTVA) In Patients With Upper Lobe Emphysema
  51. Sleep profile and symptoms of sleep disorders in patients with stable mild to moderate chronic obstructive pulmonary disease
  52. Non-CPAP therapies in obstructive sleep apnoea
  53. Polymerische Lungenvolumenreduktion (AeriSeal™) bei Patienten mit schwerem, homogenem Lungenemphysem
  54. Kardiale Komorbidität bei COPD
  55. Clinical review: Humidifiers during non-invasive ventilation - key topics and practical implications
  56. Präoperative Optimierung
  57. Insulin Resistance May Contribute To Systemic Vascular Dysfunction In Patients With COPD
  58. Knowing Chronic Obstructive Pulmonary Disease by Heart
  59. COPD and Osteoporosis: Detection and Grading of Vertebral Fractures on Lateral Chest Radiography
  60. Endothelial Function in COPD
  61. Determinants of Systemic Vascular Function in Patients with Stable Chronic Obstructive Pulmonary Disease
  62. Schlafatemstörungen
  63. Determinants of Systemic Vascular Function in Patients with Stable Chronic Obstructive Pulmonary Disease
  64. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease
  65. From a sore throat to the intensive care unit: the Lemierre syndrome
  66. Heart rate variability and spontaneous baroreflex sequences in supine healthy volunteers subjected to nasal positive airway pressure
  67. Pleural empyema associated with Gemella morbillorum: Report of a case and review of the literature
  68. Circulating plasma levels of vascular endothelial growth factor in patients with sleep disordered breathing
  69. Non-Invasive Pressure Support Ventilation in Patients with Respiratory Failure due to Severe Acute Cardiogenic Pulmonary Edema
  70. A case of primary tularemic pneumonia presenting with necrotizing mediastinal and hilar lymph nodes
  71. Some factors affecting cerebral tissue saturation during obstructive sleep apnoea
  72. Symptomatic Gastroesophageal Reflux in Subjects With a Breathing Sleep Disorder